Quickly denied at the beginning of last week, the announcement in the Zurich press of the IPO of ON Shoes had a great merit: that of recalling the worrying aversion that Swiss start-ups seem to have towards this mode of funding.
With the notable exception of ADC Therapeutics which succeeded in June a remarkable entry on the New York Stock Exchange, not a young shoot has risked itself on the public markets since the beginning of the year. Even more worrying, no new listing is on the agenda for the coming months.
–
–
Related posts:
Ex-drug dealer suspected of passing genital herpes on to his 7-year-old daughter
Airfare Prices Soar Ahead of Eid Holiday in Jakarta
Mess within 'undercover unit': police chief has to clear the field | Inland
In Estonia, it is proposed to reduce the requirements for providing printed receipts and invoices
